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Abstract
Congenital disorder of glycosylation type IIc (CDG IIc) is characterized by mental retardation, slowed growth and severe
immunodeficiency, attributed to the lack of fucosylated glycoproteins. While impaired Notch signaling has been implicated
in some aspects of CDG IIc pathogenesis, the molecular and cellular mechanisms remain poorly understood. We have
identified a zebrafish mutant slytherin (srn), which harbors a missense point mutation in GDP-mannose 4,6 dehydratase
(GMDS), the rate-limiting enzyme in protein fucosylation, including that of Notch. Here we report that some of the
mechanisms underlying the neural phenotypes in srn and in CGD IIc are Notch-dependent, while others are Notch-
independent. We show, for the first time in a vertebrate in vivo, that defects in protein fucosylation leads to defects in
neuronal differentiation, maintenance, axon branching, and synapse formation. Srn is thus a useful and important
vertebrate model for human CDG IIc that has provided new insights into the neural phenotypes that are hallmarks of the
human disorder and has also highlighted the role of protein fucosylation in neural development.
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Introduction
Congenital disorder of glycosylation, type IIc (CDG IIc), also
known as leukocyte adhesion deficiency II (LAD II) or Rambam-
Hasharon syndrome (RHS), is an autosomal recessive syndrome,
characterized by recurrent infections, persistent leukocytosis,
severe mental retardation and slowed growth [1,2]. The
immunodeficiency that is a hallmark of these syndromes is
believed to be caused by dysregulated fucose metabolism,
resulting in the absence of all fucosylated glycans on the cell
surface [1,2]. The gene responsible for CDG IIc has been
identified as GDP-fucose transporter (FUCT1) [3,4], which
translocates GDP-fucose from the cytosol into the Golgi lumen
for fucosyltransferase-catalyzed reactions during the modifica-
tion of glycans.
Several animal models have been generated to study the
pathogenesis of CDG IIc: FX locus null mice, lacking an enzyme
in the de novo GDP-fucose synthesis pathway [5], Gfr (homologous
to FUCT1) null flies [6] and Fuct1 null mice [7]. Gfr null flies
display Notch-like phenotypes during wing development and
reduced Notch fucosylation, suggesting that Notch deficiency
may be responsible for some of the developmental defects in CDG
IIc patients [6]. However, despite the neurodevelopmental and
cognitive dysfunction prominent in CDG IIc patients, the
anatomical, cellular and molecular abnormalities within the
nervous system have not been well documented, and the
mechanisms underlying this and other neural phenotypes remain
unexplored.
A large body of literature has demonstrated an important role
for Notch-Delta signaling in neur o n a la n dg l i a ls p e c i f i c a t i o n ,
neuronal maturation and learning and memory [8]. Specifically,
in zebrafish, Notch-Delta signaling has been shown to regulate
neurogenesis and gliogenesis. For instance, deficiency of
Notch1a as in deadly seven (des) mutants resulted in increased
primary motor neuron and Mauthner neuron number [9];
deficiency of Delta A as in dla mutant caused excessive primary
motor neurogenesis at the expense of secondary motor neurons,
some ventral interneurons and oligodendrocytes [10,11,12];
mutation of Mind Bomb (an E3 ubiquitin ligase for Delta) as in mib
resulted in a severe neurogenic phenotype together with the loss
of oligodendrocytes [12,13]. While some studies support the
involvement of Notch signaling in the balance of excitatory/
inhibitory synapses in hippocampus [14] and during synaptic
plasticity [15], whether Notch-Delta signaling modulates
synaptogenesis is unknown.
Here we report the genetic, cellular and molecular character-
ization of a zebrafish mutant slytherin (srn). Previously, we have
identified srn as a synaptogenic mutant that exhibits abnormal
swimming behavior, has increased primary motor neurons and
aberrant neuromuscular synaptogenesis [16]. We have found that
the srn mutation resides in GDP-mannose 4, 6-dehydratase
(GMDS), the first and rate-limiting enzyme in the fucose
metabolism pathway. Because dysfunction of the same pathway
is responsible for human CDG IIc, we performed cellular and
molecular analyses that suggest that srn has Notch-Delta
dependent and independent defects, consistent with a general
PLoS ONE | www.plosone.org 1 October 2010 | Volume 5 | Issue 10 | e13743defect in protein fucosylation that affects several aspects of neural
development.
Materials and Methods
Zebrafish maintenance and mutants
Zebrafish were raised and maintained under standard condi-
tions. The srn allele was previously described [16]. The des
b420
allele was obtained from Dr. Christine Beattie, Tg(hsp70l:GAL4)
and Tg(UAS:myc-notch1a-intra) [17] from Dr. Bruce Appel, and
dla
hi781 and mib
hi904 alleles from Zebrafish International Resource
Center, University of Oregon.
Positional cloning of srn
Genetic mapping of mutant loci was performed as described [18].
New simple sequence repeat (SSR) markers DKEY-25E12-SSR2
(forward, 59-gcacacatgcatacgttcag-39;r e v e r s e ,5 9-tcccaaagtgaaagggt-
gag-39) and DKEY-177P2-SSR4 (forward, 59-cctgagggtcaggagag-
taatg-39; reverse, 59-gaactaacactttcacaaacaccaa-39)w e r eu s e dt o
define the interval that contained the mutation. PCR products
containing the entire ORF of gmds (accession # NM_200489) were
generated with the primers 59-cggatgtgtttgcatccgta-39 and 59-
tcacatgaattaaacggcat-39 for both mutant and WT (WT) cDNAs,
cloned into pCR4-TOPO(Invitrogen),and sequenced for validation.
RNA extraction and quantitative RT-PCR (qRT-PCR)
RNA was extracted (20 embryos) with the RNeasy kit (Qiagen,
Inc.). hes5 was amplified with primers 59-gaaagccagtggtggaaaag-39
and 59-gaaagccagtggtggaaaag-39. her4 was amplified with primers
59-cctggagatgacgcttgatt-39 and 59-cactgggcactgagacagaa-39. heyl
was amplified with primers 59- gcgatacctcagctctttgg-39 and 59-
ggagaggatccagctcactg-39. b-actin1 was amplified with primers 59-
tgaatcccaaagccaacagagaga-39 and 59-tcacgaccagctagatccagacg-39.
qRT-PCR was performed with the SuperScriptH III PlatinumH
SYBRH Green One-Step qPCR Kit w/ROX (Invitrogen) and
data was analyzed with 7500 Real-Time PCR System software
(Applied Biosystems) using the 2
-DCT method.
Whole mount in situ hybridization
gmds cDNA was cloned into pBluescript (Stratagene). The
plasmid was linearized and anti-sense and sense probes were made
with the Dig RNA labeling kit SP/T7 (Roche). hes5 in situ probe
was generated with primers 59-tggctcctgcgtatatgactgaat-39 and 59-
gcggctcctgcttgatgtgt-39. her4 in situ probe was generated with
primers 59-tctgatcctgacggagaactg-39and 59-ttcagtccatgccaatctca-39
[19]. heyl in situ probe was generated with primers 59-tcaacca-
cagcctgtcagag-39 and 59-caggggaatgctgttgaagt-39 [20]. In situ
hybridization was performed as described previously [16].
GDP-fucose rescue and gmds mRNA and morpholino
injection
GDP-fucose (50 mM in water (pH=7) with 0.1% phenol red as a
tracer) was injected directly into 1–2 cell stage embryos collected
from crosses of srn carriers. Gmds-gfp mRNAs (WT and srn)w e r e
injected into embryosfromWTand srn incrosses at the 1–2 cellstage
at,200 pg.The morpholinoantisense oligonucleotide (Gene Tools)
targeting the gmds exon5-intron5 junction (CGTATGTTTGCT-
GACCATAAGGCGA) was injected at the 1–2 cell stage at ,4n g .
Expression of Notch1a by heat-shock induction and
rescue of gmds morphant phenotypes
To induce expression of constitutively active Notch1a (Notch1a
intracellular domain, NICD), embryos were collected from
matings of heterozygous Tg(hsp70l:GAL4) and Tg(UAS:myc-
notch1a-intra) adults and raised at 28.5uC. At 11 hpf, embryos
were heat-shocked at 39uC for 30 minutes and then returned to
28.5uC until the desired stage of development [21]. To determine
whether NICD rescues srn phenotypes, gmds MO was injected into
NICD transgenic embryos and the phenotypes were compared to
NICD transgenic embryos alone, WT, srn and gmds MO embryos.
DAPT treatment
Embryos were dechorionated with forceps at 6 hpf and placed
in DAPT (N-[N-(3,5-Difluorophenacetyl-l-alanyl]-S-phenylgly-
cine-t-butyl ester; Calbiochem) solution at 28.5uC until the
appropriate stage, as previously described [22]. For experiments,
50 mM (medium dose) and 100 mM (high dose) DAPT in embryo
medium containing 1% DMSO was used. Control embryos were
incubated in an equivalent concentration (1%) of DMSO.
Immunostaining, AAL staining and labeling of
retinotectal projections
Embryos were anesthetized, fixed and immunostained as
described previously [16] using antibodies against SV2, Zn5,
3A10, Islet1/2, F59 (all from Developmental Studies Hybridoma
Bank, Univ. of Iowa) and/or goldfish GFAP [23] (gift from Drs. S.
Nona and J. Scholes, Univ. of Sussex, United Kingdom) and
fluorescently conjugated secondary antibodies (Jackson Labs, Inc.).
Fluorescently conjugated a-bungarotoxin (Molecular Probes, Inc.)
was used to label AChRs [16]. TUNEL staining was performed
according to the manufacturer’s instructions (Chemicon, Inc.).
Fucosylated proteins were visualized in 48 hpf embryos using a
biotinylated fucose-specific lectin, Aleuria Aurantia lectin (AAL;
20 mg/ml; Vector Labs; [24,25] followed by Alexa 488 conjugated
strepavidin (20 mg/mL; Molecular Probes). The number of Zn5+
cells was counted at 20 mm intervals along the rostral-caudal axis
of several spinal cord hemisegments and compared statistically
using Kolmogorov-Smirnov test. Retinal ganglion cell axon
projections to the optic tectum were labeled as described [26].
Unless otherwise stated, each immunostaining or dye labeled
figure panel is a single plane projection of a confocal z-stack of 20–
160 1 mm thick planes (Leica TCS 4D). Presynaptic vesicles,
AChR clusters and the co-localization of these two markers were
measured from using interactive software (Metamorph).
Results
External phenotype, genetic cloning and mRNA rescue of
slytherin
Externally, srn mutants exhibit a bent tail as early as 24 hpf, a
phenotype that becomes progressively more severe (Fig. 1A), as
well as a malformation of the hindbrain, which becomes apparent
at 48 hpf (Fig. 1A, brackets). The srn locus was mapped between
SSLP markers z49730/z14955 and z14614 on chromosome 20,
with marker z10756 having no recombinants (Fig. 1B). Gmds was
found to contain a G to T transversion in the nucleotide sequence
that produces a nonconservative glycine (G) to valine (V)
substitution of amino acid 178 (G178V) in the short-chain
dehydrogenase/reductase (SDR) domain (Fig. 1C, D, E). GMDS
is highly conserved at the amino acid level; the fish and human
proteins are 87% identical.
In situ hybridization showed that from 6 to 12 hpf, gmds
transcripts are expressed throughout the embryo (Fig. S1A). By 24
hpf, gmds transcripts are enriched in the CNS and are also present
in somites (Fig. S1B). Gmds mRNA expression is present in the
CNS at 48 and 72 hpf, with transcripts more abundant in brain
than spinal cord (Fig. S1C, D). Gmds mRNA is also expressed in
Zebrafish Model of CDGIIc
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shown; [27]).
RT-PCR analyses suggested that at least two splice variants
exist in zebrafish gmds, with or without exon 4, which we name
gmds-L and gmds-S respectively. Both splice variants are expressed
in srn mutants and WT embryos (Fig. 1F). To confirm that gmds is
the gene responsible for srn phenotypes, both splice variants of the
WT and mutant gmds cDNAs were fused with gfp and were in vitro
transcribed into mRNA and were injected into 1–2 cell stage
embryos collected from srn incrosses. In embryos injected with WT
gmds-gfp mRNAs, 5% were mutant scored by external phenotypes
compared to uninjected embryos (29%) or embryos injected with
mutant gmds-gfp mRNAs (Fig. 1G; one-way ANOVA, followed by
Dunn’s pairwise comparison, p,0.05). Moreover, when GMDS
function was perturbed in WT embryos with a splice-blocking
morpholino, all defects seen in srn mutants were phenocopied (see
below and Fig. S3). These experiments confirm that gmds is the
gene mutated in srn.
Slytherin mutants exhibit reduced protein fucosylation
GMDS is the first enzyme in the de novo fucose metabolism
pathway, catalyzing the conversion of GDP-D-mannose to GDP-
4-keto-6-D-deoxymannose, which is further processed into GDP-
fucose [5] and transported into the Golgi where it is used to
Figure 1. Slytherin external phenotype, genotype, cloning and mRNA rescue of srn mutants. A. External srn phenotypes at 48 hpf include
a bent tail (80% dorsal (534 embryos, 8 carrier pairs)) and aberrant hindbrain formation (brackets). Scale bar =100 mm. B. Genetic and physical map
of the srn locus (red arrow), including SSLP markers, number of recombinants, BAC clones and megabase positions from Ensembl Zv7. C, D. In srn,
Gmds mutation is G to T (C, red box) resulting in a Glycine to Valine conversion (D, red box). GMDS amino acid sequence is highly conserved. E.
Schematic of srn mutation in the short-chain dehydrogenase/reductase (SDR) domain of GMDS. F. Two splice variants exist in gmds mRNA, with
(gmds-L, 377 aa) or without (gmds-S, 370 aa) exon 4. Gmds alternative splicing is not altered in srn mutants. G. Injection of gmds mRNA rescues srn
mutants. Compared to uninjected embryos, 28.661.2% of embryos were mutant when scored by external phenotypes (3413 embryos, 27 carrier
pairs). In embryos injected with WT gmds-gfp mRNA, the percentage of mutants scored by external phenotypes was significantly decreased, to ca. 5%
(gmds-wtL-gfp 5.462.5%, 401 embryos, 3 carrier pairs; gmds-wtS-gfp 5.160.6%, 587 embryos, 4 carrier pairs; one-way ANOVA, followed by Dunn’s
pairwise comparison, p,0.05). The percentage of embryos with mutant external phenotypes was unchanged in embryos injected with mutant gmds-
gfp mRNA (gmds-srnL-gfp 30.260.9%, 387 embryos, 3 carrier pairs; gmds-wtS-gfp 25.161.9%, 516 embryos, 4 carrier pairs). This mRNA rescue
experiment confirms that gmds is the gene responsible for srn mutation.
doi:10.1371/journal.pone.0013743.g001
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PLoS ONE | www.plosone.org 3 October 2010 | Volume 5 | Issue 10 | e13743fucosylate proteins, including Selectins, Notch and many others
[5,28,29]. Thus AAL staining for fucosylated proteins was
performed in 48 hpf WT and mutant embryos (Fig. 2).
In WT embryos, AAL staining was detected in many tissues
(Fig. 2A), including olfactory bulb, retina, optic tectum, hindbrain
and spinal cord (Fig. 2B–E), which prompted us to examine the
potential phenotypes in these structures in srn.M o r e o v e r ,a t
neuromuscular junctions (NMJ), AAL staining co-localizes with
markers for pre- and postsynaptic specializations, such as SV2 and
acetylcholine receptors (AChRs) (Fig. 2K–N). In contrast, AAL
stainingis stronglyreduced in srn mutants(Fig.2F–J,O–R),consistent
with analyses of cells from CDG IIc patients [3,4], and of Drosophila
Gfr mutants [6]. These studies show that protein fucosylation is
dramatically reduced in the CNS and other tissues in srn, consistent
with a loss of function of GMDS, confirming a prediction based on
t h em o d e l i n go ft h ep r o t e i nc r y s t a ls t r u c t u r e( s e eF i g .S 2 ) .
A  WT
AAL SV2 AChRs L  AAL   M          N
F srn
O K
B  Retina C  Optic tectum G  Retina H  Optic tectum
D  Hindbrain E  Sp Cd + Muscle I  Hindbrain J  Sp Cd + Muscle
P           Q          R
Figure 2. slytherin mutants exhibit reduced protein fucosylation as measured by AAL staining. A. AAL staining of WT embryos at 48 hpf
showed that protein fucosylation is present throughout the embryo (10–15 embryos/2–3 adult pairs for all analyses). B–E. Protein fucosylation is
prominent in several neural tissues including retina (lateral view), optic tectum (dorsal view), hindbrain (lateral view), spinal cord (lateral view) and
neuromuscular synapses (lateral view of axial muscle). F. Protein fucosylation is dramatically reduced in srn mutants. Scale bar =20 mm. G–J.
Reduced protein fucosylation in several neural tissues. Scale bar =20 mm. K. Protein fucosylation at neuromuscular synapses in WT embryos at 48
hpf, as shown by the colocalization of AAL staining (green) with markers for presynaptic axons and nerve terminals (SV2, red) and postsynaptic AChR
clusters (a-bungarotoxin, blue). L–N. Higher magnification of boxed region in K. O. Protein fucosylation is reduced at srn neuromuscular synapses.
Scale bar =20 mm. P–R. Higher magnification of boxed region in O. Synapse area is significantly increased in srn mutants, e.g., at the choice point
(compare dashed bracket in Q to solid bracket in M). Scale bar =20 mm.
doi:10.1371/journal.pone.0013743.g002
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phenotypes
Since GMDS functions early in the fucose metabolism pathway,
we reasoned that exogenous supply of downstream products may
circumvent the genetic defect in srn. Therefore, 50 mM GDP-
fucose was injected into 1–2 cell stage embryos collected from srn
incrosses. Compared to uninjected embryos, the percentage of
mutant embryos, as scored by external phenotypes (Fig. 3A), was
dramatically reduced in GDP-fucose injected embryos (Fig. 3B).
Moreover, AAL staining was similar to that in WT embryos at 48
hpf in many if not all tissues (Fig. 3C). Detailed phenotypic
analyses further showed that GDP-fucose supplementation is
sufficient to rescue neural defects in srn mutants (see below and Fig.
S3). These strongly suggest that the absence of GDP-fucose, as a
result of GMDS dysfunction, is the cause of the srn mutant
phenotypes, rather than the accumulation of the substrate, GDP-
mannose. Thus srn mutants display dysregulated protein fucosyla-
tion, as is seen in human CDG IIc patients, and that GDP-fucose
supplementation restores fucosylation and rescues defects in srn.
Slytherin mutants exhibit defects in neuron and glia
number, identity, patterning and axon outgrowth due to
Notch-Delta signaling reduction
Our previous work suggested that srn exhibited a neurogenic
phenotype, specifically an increased number of primary motor
neurons [16], similar to that observed in mutants in the Notch-
Delta pathway. Analyses of Drosophila Gfr mutants suggested that
Notch fucosylation is reduced, and that a reduction in Notch
signaling might contribute to the pathogenesis in CDG IIc [6].
Therefore, we asked which if any neural defects in srn were similar
to those observed in mutants in the Notch-Delta pathway or in
embryos treated with the c-secretase inhibitor DAPT to reduce
Notch signaling.
We compared srn phenotypes with known mutants in the Notch-
Delta pathway, des
b420 (deadly seven, a nonsense mutation in notch1a
yielding a truncated protein; Gray et al., 2007), dla
hi781 (delta A,a n
insertion in delta A, predicted to result in a truncated protein [30])
and mib
hi904 (mind bomb, an insertion in an E3 ligase that targets
Delta and other proteins for ubiquitination [13], predicted to
result in a truncated protein [31]). Below we describe phenotypes
in each mutant in order of increasing disruption of Notch-Delta
signaling.
First, we examined secondary motor neuron cell body number
and patterning in the spinal cord, and axon projections in muscle
using Zn5 immunostaining. In srn mutants at 48 hpf and 72 hpf,
while the number of Zn5+ cells is similar between srn mutant and
WT embryos (Fig. S4), the patterning of these cells is aberrant.
Cell bodies are clumped in srn mutants (Fig. 4A, B, second panel,
dashed blue bracket), compared to evenly spaced cell bodies in
WT embryos (Fig. 4A, B, top, solid blue bracket). The dorsally
projecting nerve also is absent in srn mutants (Fig. 4A, B, second
panel, dashed pink oval), consistent with increased Zn5+ cell death
[16]. des mutants do not have defects in Zn5+ cell number or
patterning, but do have motor axon pathfinding errors, possibly
due to aberrant formation of somite boundary (Fig. 4A; [9]). dla
mutants do not have defects in Zn5+ cell number, but have similar
aberrant patterning as in srn mutants, without the loss of the dorsal
projecting nerve (Fig. 4A, B, dashed blue bracket and solid pink
oval, respectively). mib mutants have aberrant Zn5+ cell number
and patterning that is apparent at 48 and 72 hpf, as well as loss of
the dorsal nerve.
To analyze the Zn5+ cell patterning defects quantitatively, we
counted the number of Zn5+ cells at every 20 mm interval along
the rostral-caudal axis of several spinal cord hemisegments. This
analysis showed that, while there are 3–5 Zn5+ cells every 20 mm
in WT and des mutants, there are 1–9 in srn and dla, and 0–3 in
mib, confirming our visual impression that patterning is aberrant
(Fig. S5E–F). Moreover, while Islet1/2+ cells are dramatically
increased in srn mutants at 24 hpf, consistent with increased
primary motor neurons (Panzer et al., 2005), these cells are
decreased at 48 hpf and the majority of Zn5+ cells lack Islet1/2
expression in srn mutants (Fig. S5). As Zn5 is expressed in
secondary motor neurons and is colocalized with Islet1/2 in wild
type embryos, and that Islet1/2 is reduced in Zn5+ cells in srn, our
results suggest the patterning defects in Zn5+ cells may be
correlated with the aberrant Islet1/2 expression. There may be a
defect in secondary motor neuron specification in srn, consistent
with a role for Islet1 and Islet2 in secondary motor neuron
formation and axonogenesis [32].
We also found that in the spinal cord, the number of Rohon-
Beard neurons is also significantly increased in srn mutants at 24
and 48 hpf (Fig. S5A–B), similar to dla mutants [33], consistent
with reduced Notch-Delta signaling in srn mutants.
Figure 3. Supplementation with exogenous GDP-fucose res-
cues srn external phenotypes and restores AAL staining. A.
External srn phenotypes including bent tail and aberrant hindbrain
(bracket) are rescued by GDP-fucose supplementation (3 embryos).
Scale bar =100 mm. B. GDP-fucose injection significantly reduced the
percentage of mutants from 28.661.2% to 8.462.7% (576 embryos, 4
carrier pairs; Student’s test, p,0.0001). C. After GDP-fucose supple-
mentation (2 embryos), protein fucosylation as assessed by AAL
staining at 48 hpf is rescued throughout srn embryos, to levels similar
to those in WT embryos. Scale bar =100 mm.
doi:10.1371/journal.pone.0013743.g003
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PLoS ONE | www.plosone.org 5 October 2010 | Volume 5 | Issue 10 | e13743Figure 4. Reduction in Notch-Delta signaling accounts for some srn phenotypes. A, B. Secondary motor neuron cell body number and
patterning assayed with Zn5 immunostaining (18 embryos/3 carrier pairs for each). B. Higher magnification of boxed region in A. At 48–72 hpf, Zn5+
cell number is similar in srn and WT (Fig. S4), but the patterning of these cells is aberrant in srn embryos. Zn5+ cells are clumped in srn mutants
(dashed blue bracket) compared to WT embryos (solid blue bracket). dla mutants do not have defects in Zn5+ cell number (Fig. S4), but have aberrant
Zn5+ cell patterning as in srn mutants (dashed blue bracket). mib mutants and high dose DAPT treated embryos have aberrant Zn5+ cell number (Fig.
S4) and patterning (dashed blue bracket). Medium dose DAPT treated embryos show aberrant Zn5+ cell patterning defects (dashed blue bracket),
without an obvious change in cell number (Fig. S4), as in srn. The dorsal projecting nerve is absent in srn mutants (dashed pink oval) compared to WT
(solid pink oval), consistent with increased cell death; this nerve is present in dla and des mutants (solid pink oval); des also has other motor axon
pathfinding errors. In mib mutants and high and medium dose DAPT treated embryos, the dorsal projecting nerve is absent (dashed pink oval). C. In
WT embryos at 48 hpf, two Mauthner neurons are present (dorsal view of hindbrain). In srn, des, dla, mib and high dose DAPT treated embryos,
Mauthner neuron number is increased (dashed red brackets), with the largest increase observed in mib (12 embryos, 3 carrier pairs for each). D. In the
Zebrafish Model of CDGIIc
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and patterning are present. In the hindbrain at 48 hpf, an increase
in Mauthner neurons is observed in srn, des (as previously reported,
Gray et al., 2001), dla and mib, with the largest increase in
Mauthner neuron number observed in mib (Fig. 4C, red brackets).
Moreover, neuronal patterning in the hindbrain is severely
perturbed in srn and in mib (data not shown). In the retina at 72
hpf, cell number and patterning appear grossly normal in srn, des
and dla, but in mib, retinal ganglion cell number is reduced (Fig.
S6A), probably due to increased cell death, as previously reported
[34]. These data suggest that reduced Notch-Delta signaling may
account for some of the CNS and PNS phenotypes observed in srn.
Because deficiencies in Notch-Delta signaling have been shown to
result in reduced gliogenesis [10,11,12,13], we examined glial cells in
the spinal cord, hindbrain and retina with GFAP immunostaining. In
the spinal cord and hindbrain, the number of GFAP+ glial cells is
reduced in srn mutants compared to WT embryos at 48–72 hpf
(Fig. 4D, 4E and data not shown). A similar reduction in GFAP+ glial
c e l l si sa l s oo b s e r v e di ndla and mib,b u tn o ti ndes (Fig. 4D, 4E and data
not shown). In the retina, the number of radially oriented GFAP+
Muller cells is decreased in srn and mib,b u tn o ti ndes or dla (Fig. S6B).
These results suggest that a reduction in Notch-Delta signaling may
account for the reduction in glia observed in srn mutants.
We then compared srn phenotypes with those caused by Notch
signaling inhibitor DAPT, a c-secretase inhibitor, that prevents
intramembrane proteolysis of Notch and thus decreases the
downstream signaling dependent on the Notch intracellular domain
[22]. While high dose of DAPT treatment resulted in phenotypes
resemblingthoseseeninmib ( F i g .4a n dF ig .S 6 ) ,m e d i u md o s eD A PT
treatment closely recapitulated srn phenotypes, including the Zn5+
cell patterning defects and the reduction of GFAP+ glial cells in the
spinal cord and retina (Fig. 4; Figs. S5, Fig. S6). These results
substantiate the conclusion that a reduction in Notch-Delta signaling
may account for the observed neural defects in srn mutants.
In order to test the synergy between srn and Notch-Delta
deficiency, we initially sought to examine embryos double
heterozygous for srn and mib, but these embryos did not show any
obviousdefects,likelybecausebothsingle heterozygousembryosare
haploid sufficient. We also examined embryos double homozygous
for srn and mib, reasoning since Notch signaling is mostly if not
completely absent in mib [13], if srn defects are also caused by Notch
signaling deficiency, introducing srn into mib background would not
result in addictive effects, i.e. would not be more severe then mib.
Indeed, srn and mib double mutants showed reduced Zn5+ cells and
GFAP+ glial cells in the spinal cord, closely resembling those seen in
mib (Fig. 5). Furthermore, using the same reasoning, we tested the
synergy between srn and DAPT treatment. Similarly, in DAPT high
dose treated embryos, in which Notch signaling is mostly if not
completely blocked, srn did not add to the defects caused by DAPT
alone, i.e. DAPT treated srn mutants resembled DAPT treated WT
embryos showing similar reduced Zn5+ cells and GFAP+ glial cells
in the spinal cord (Fig. 5). These results are consistent with the
hypothesis that Notch signaling deficiency underlies the neurogen-
esis and gliogenesis defects in srn.
If the observed neural defects in srn results from reduced Notch
signaling, then overexpressing constitutively active Notch would
rescue these phenotypes. We utilized transgenic lines in which a
constitutively active form of Notch, Notch1a intracellular domain
(NICD) is overexpressed under the heat-shock promoter
(Tg(hsp70l:GAL4); Tg(UAS:myc-notch1a-intra)) [17], recapitulated srn
phenotypes in these embryos by morpholino knockdown of gmds
transcripts, and examined whether NICD rescued the neural
defects. Indeed, NICD overexpression rescued the Zn5+ cell
patterning and reduced GFAP+ glial cells phenotypes in gmds
morphants (Fig. 6). Moreover, NICD overexpression suppressed
the increased mauthner neuron phenotype in gmds morphants (Fig.
S7). These results strongly suggest that Notch signaling deficiency
underlies the neurogenesis and gliogenesis defects in srn.
To further assess whether Notch-Delta signaling is deficient in srn
mutants, we examined the expression of several Notch effector
genes, including hes5, her4 and heyl as direct readout of Notch
transcriptional activation, usingrealtime quantitative RT-PCR and
in situ hybridization. mib embryos display a strong reduction in
Notch signaling [13] and hes5, her4 and heyl were collectively shown
to be reduced in mib mutant fish and/or mice [35,36,37,38,39]. We
found that, at 48 hpf, hes5, her4 and heyl expression were significantly
reduced in srn mutants, similar as in mib mutants, although to a
lesser extent (Fig. 7A, B). Because these data show that defects in
neuron and glia number, patterning and Notch effector genes
expression in srn mutants are similar to those observed in mutants in
the Notch-Delta pathway, a reduction in Notch-Delta signaling
caused by the lack of fucosylation accounts for these srn phenotypes.
Slytherin mutants exhibit defects in neuromuscular
synaptogenesis due to Notch-Delta signaling reduction
Because srn was first identified in a screen for mutants with
defects in neuromuscular synaptogenesis, we assessed the role of
protein fucosylation and Notch-Delta signaling in neuromuscular
synapse formation, particularly at the choice point where the first
neuromuscular synapses are made [16]. Choice point neuromus-
cular synapse size was increased at 24 hpf in srn, des, dla, mib and
DAPT treated embryos (Fig. 8). At 48 hpf, mib and DAPT treated
embryos showed no enlargement of choice point neuromuscular
synapses, likely due to a reduced number of secondary motor
neurons (Fig. S4). These defects are not due to defects in muscle
fiber integrity or number (Fig. S8 and [16]). These results show
that dysregulated protein fucosylation in srn mutants resulted in an
aberrant neuromuscular synaptogenesis that was phenocopied in
Notch-Delta signaling deficient embryos, suggesting that Notch-
Delta signaling plays an important and previously unappreciated
role in neuromuscular synapse formation.
Slytherin mutants exhibit defects in CNS axon branching
and synaptic connectivity that are independent of Notch-
Delta signaling
Phenotypic analyses showed that srn has several defects that are
not presentin mutants in the Notch-Delta pathway des, dla or mib,o r
DAPT treated embryos. In the retina, while overall cellular
lamination is grossly normal in srn mutants (Fig. 9E, bottom left
panel), neuropil in the outer and inner plexiform layers (OPL and
IPL) are dramatically altered (Fig. 9A, arrowheads and arrows). In
srn mutants at 48–72 hpf, the OPL and IPL synaptic layers are
disorganized, and this is not seen in des, dla or medium dose DAPT
treated embryos (Fig. 9A). In mib and high dose DAPT treated
spinal cord, the number of GFAP+ glial cells is reduced in srn and dla mutants and medium dose DAPT treated embryos compared to WT and des
embryos at 48–72 hpf. In mib and high dose DAPT treated embryos, a more dramatic reduction is observed. The GFAP labeling that remains in mib
mutants is likely to be in Rohon-Beard neurons dorsally and secondary motor neurons ventrally and is easily separated morphologically and based on
its location from glial processes, thus does not interfere with analyses of glial defects (18 embryos, 3 carrier pairs for each). E. Overlay showing both
the Zn5 and GFAP staining in the spinal cord. Scale bars =40 mm.
doi:10.1371/journal.pone.0013743.g004
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reduction in synapses throughout the retina (Fig. 9A). Thus srn
displayed unique defects in CNS synaptic connectivity that are not
phenocopied by Notch signaling deficient embryos. These data are
consistent with one of two possibilities. First, fucosylation of proteins
other than those involved in Notch-Delta signaling may be required
Figure 6. NICD rescues srn neuro- and gliogenesis phenotypes. A. AAL staining is reduced in srn, gmds morphants and gmds morphants
overexpressing NICD, but not in WT embryos or WT embryos overexpressing NICD. B. WT and WT overexpressing NICD had normal Zn5+ cell
patterning. srn and gmds MO showed Zn5+ cell patterning defects which was rescued by NICD overexpression in gmds morphants. C. WT and WT
overexpressing NICD had normal GFAP+ glia cells in spinal cord. srn and gmds morphants had reduced GFAP+ glia cells, rescued by NICD
overexpression in gmds morphants (.10 embryos in each experiment). Scale bar =40 mm. D–E. Quantification of Zn5+ cell patterning defects. There
are 3–5 Zn5+ cells every 20 mm in WT, WT overexpressing NICD and gmds MO overexpressing NICD; compared to 1–8 in srn and gmds MO embryos.
D, data from a representative embryo; E, distribution of all embryos (4–6 embryos; Kolmogorov-Smirnov test, * p,0.05).
doi:10.1371/journal.pone.0013743.g006
Figure 5. mib and DAPT treatment exclude srn phenotypes. A–C. mib excludes srn phenotypes. A. AAL staining is reduced in srn and srn +
mib double mutants, but not in mib. B. srn + mib double mutants showed reduction of secondary motor neurons, more severe than srn but similar to
mib alone. C. srn + mib double mutants have reduced GFAP+ glia, more severe than srn, but similar to mib alone (15 embryos, 2 carrier pairs for each).
Scale bar =40 mm. D–F. DAPT treatment excludes srn phenotypes. D. AAL staining is reduced in srn and srn mutants treated with DAPT, but not in
DAPT treated embryos. E. srn mutants treated with DAPT showed reduction of secondary motor neurons, more severe than srn but similar to DAPT
treated embryos. F. srn mutants treated with DAPT showed reduction of GFAP+ glia, more severe than srn, but similar to DAPT treated WT embryos
(10 embryos, 2 carrier pairs for each). Scale bar =40 mm.
doi:10.1371/journal.pone.0013743.g005
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signaling may contribute, in a specific spatio-temporal context, to
these defects. Resolution of these possibilities will require identifi-
cation of protein targets of srn-mediated fucosylation and explora-
tion of their role in CNS synaptic connectivity, and/or analyses of
mutants with more precise spatial and temporal disruption of
Notch-Delta signaling than are currently available.
Given that AAL staining showed high levels of protein fucosylation
in optic tectum (Fig. 2), we examined whether retinal ganglion cell
axon outgrowth to and branching within the optic tectum was affected
in srnand other mutants.In srn mutants,retinal ganglion axons grow to
the correct location (Fig. 9B), but their axons are aberrantly branched
within the optic tectum (Fig. 9B, dashed white circle) and medial axon
projections are shifted towards the midline (Fig. 9B, compare solid
arrow and dashed arrow). These phenotypes are not present in des, dla
or medium dose DAPT treated embryos (Fig. 9B). In mib and high
dose DAPT treated embryos, the retinal ganglion cell axon projection
to optic tectum is dramatically reduced due to retinal ganglion cell
death (Fig. 9B). Mib and high dose DAPT treated embryos also
displayed retinal ganglion axon pathfinding errors at the optic chiasm
(Fig. 9B, dashed square) and decreased branching within the optic
tectum (Fig. 9B, dashed white circ l e ) .F u r t h e r m o r e ,t o p o g r a p h i c
mapping analyses, in which the dorsonasal (DN) and ventrotemporal
(VT) retinal ganglion cell projections were differentially labeled
( F i g .9 C ,D )s h o w e dt h a t ,i nsrn mutants, the location of the DN and
VT axon projections in the optic tectum is aberrant, and that these
projections overlap aberrantly dorsally and laterally (Fig. 9D).
Moreover, the cellular lamination and cell viability in the optic tectum
was similar between srn and WT embryos at 72 hpf (Fig. 9E, middle
left panels). These results suggest that signaling independent of the
Notch-Delta pathway, but requiring protein fucosylation, modulates
axon branching and synaptic patterning in the CNS.
Discussion
We report that the srn mutation causes a loss of GMDS
function, leading to a severe reduction in protein fucosylation,
including that of Notch among many others. Srn displays increased
Figure 7. srn mutants showed aberrant expression of Notch responsive genes similar to mib mutants. A. qRT-PCR assessment of fold
change in hes5, her4 and heyl expression in WT, srn and mib mutant embryos at 48 hpf, normalized to b-actin1. hes5, her4 and heyl expression is
dramatically reduced in srn, similar to those in mib, but to a lesser extent. (3–5 experiments, 20 embryos each, one-way ANOVA, Bonferroni’s Multiple
Comparison Test, ** p,0.001, * p,0.5). B. hes5, her4 and heyl in situ hybridization at 48 hpf confirm reduced expression in the brain and spinal cord
in srn mutants compared to WT (.30 embryos for each). Scale bar =100 mm.
doi:10.1371/journal.pone.0013743.g007
Zebrafish Model of CDGIIc
PLoS ONE | www.plosone.org 10 October 2010 | Volume 5 | Issue 10 | e13743neurogenesis, decreased gliogenesis, increased neuronal cell death,
abnormal neuronal patterning, abnormal axon arborization, and
abnormal neuromuscular and CNS synaptic connectivity, indicat-
ing that protein fucosylation plays an important role in several
aspects of neural development.
Notch-Delta signaling reduction underlies some but not
all srn neural phenotypes
Our results suggest that both Notch-dependent and -indepen-
dent mechanisms contribute to the neural phenotypes observed in
srn. Srn mutants showed reduced Notch transcriptional activity, as
assayed by hes5, her4 and heyl expression, increased primary motor
neuron, Rohon-Beard neuron and Mauthner neuron number,
decreased gliogenesis and abnormal neural patterning. These
defects are phenocopied by mutants in the Notch-Delta pathway
and in embryos with reduced Notch signaling. That mib and Notch
signaling inhibition by DAPT occlude srn defects, and that NICD
overexpression rescues these srn phenotypes, strongly suggest that
the dysregulated fucosylation of proteins in the Notch-Delta
pathway accounts for these prominent neural defects in srn
mutants. While the lack of anti-zebrafish Notch antibodies
prevented direct analysis of Notch fucosylation, Notch is known
to be fucosylated, and other proteins in the Notch-Delta pathway,
including Delta, Serrate and Jagged, contain consensus sequence(s)
for O-linked fucose modification [40,41,42]. Notch is also N-
fucosylated, in which fucose is added to N-linked glycan side
chains [6,43,44]. Notch O- and N-fucosylation has been shown to
be reduced in the Drosophila Gfr null [6]. It thus seems highly
Figure 8. Slytherin mutants exhibit defects in neuromuscular synaptogenesis due in part to reduction in Notch-Delta signaling. A–X.
Presynaptic terminals (green) and postsynaptic AChR clusters (red) in 24 and 48 embryos from WT (A, G, M, S), srn (B, H, N, T), des (C, I, O, U), dla (D, J,
P, V), mib (E, K, Q, W) and DAPT treated embryos (F, L, R, X). Boxed regions are shown at higher magnification at 24 (G–L) and 48 hpf (S–X; 3
hemisegments in each of 20 embryos, 3 carrier pairs for each). Scale bar =20 mm. Y. Presynaptic terminal, axon and synapse area at the choice point
was significantly increased in all mutants, except in mib and DAPT treated embryos at 48 hpf, compared to WT (one-way ANOVA, Bonferroni’s
Multiple Comparison Test, ** p,0.01, *** p,0.001).
doi:10.1371/journal.pone.0013743.g008
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is aberrant in srn mutants and that this accounts for some, but not
all, srn neural phenotypes.
Interestingly, there is a hierarchy in the spectrum of phenotypes
amongsrn and mutant in the Notch-Delta pathway. Phenotypes in
des, except for the axon pathfinding errors, are weaker than those
in dla, and both of these are weaker than srn. This is consistent
with the hypothesis that many Notch-Delta factors, including
Notch, Delta, Serrate and Jagged, require proper protein
fucosylation and compromised fucosylation of these proteins
may account for the wider spectrum of defects seen in srn. Mib
mutants also displayed a wide range of defects, not seen in the
other three mutants, both due to the fact that mib regulates a large
spectrum of Notch signaling, as it interacts with various Notch
ligands and is broadly required for Notch signaling in many
tissues, and also it interacts with a number of proteins besides
Delta and may serve as an integrator of multiple neuronal
developmental pathways [45].
Moreover, our observation that srn and mutants in the Notch-
Delta pathway have increased neuromuscular synapses supports a
previously underappreciated role for Notch-Delta signaling during
synaptogenesis. Because primary motor neuron number is
increased in srn, it is difficult to separate direct effects of Notch-
Delta signaling on presynaptic differentiation from indirect effects
on neurogenesis. The total number of motor neurons innervating
trunk muscles actually decreases due to secondary motor neuron
cell death [16], while the increase in neuromuscular synapse
number and size persists. This strongly suggests that Notch-Delta
Figure 9. Slytherin mutants exhibit defects in axon branching and CNS synaptic connectivity that are independent of Notch-Delta
signaling. A. In srn mutants at 72 hpf, the OPL (arrowheads) and IPL (arrows) are disorganized; this is not seen in des or dla mutants. In mib mutants,
retinal ganglion and other cells die, resulting in decreased retina neuropil (rightmost panel; 8 embryos, 2 carrier pairs for each). Scale bar =20 mm. B.
In srn mutants, retinal ganglion cell axons grow out to the optic chiasm and to optic tectum, but axon branches are aberrantly distributed within
tectum (dashed white circle) and medial axon projections are shifted towards the midline (compare solid arrow and dashed arrow). Virtually all retina
was dye labeled, and the labeling pattern was consistent across experiments, thus these defecs aren’t due to incomplete dye uptake or labeling in srn
mutants. These phenotypes are not present in des or dla mutants, and are also different from mib mutants, in which retinal ganglion cell axonal
projections to optic tectum are dramatically reduced, as a consequence of retinal ganglion cell death. Mib mutants also displayed axon pathfinding
errors at the optic chiasm; axons branched anterior to the optic chiasm (dashed square), while branching within tectum was dramatically reduced
(dashed white circle; 15 embryos, 3 carrier pairs for each). Scale bar =20 mm. C, D. Topographic mapping of axon projections to optic tectum;
dorsonasal (DN) and ventrotemporal (VT) axons were with DiI or DiD. DN and VT axon projections within tectum are aberrant in srn mutants, as is
overlap dorsally (C) and laterally (D; 8 embryos, 2 carrier pairs for each). Scale bar =20 mm. E. In retina and optic tectum (white circle), the overall
cellular lamination pattern as assessed by DAPI staining is grossly normal in srn mutants (compare bottom left panels, WT and srn). TUNEL staining
showed that increased cell death was observed in the retina of srn mutants compared to WT embryos at 72 hpf; no difference in cell death in the
optic tectum was observed in srn mutants compared to WT embryos at 72 hpf (color overlay, right most panels; 2–3 embryos, 1 carrier pair). Scale
bar =20 mm.
doi:10.1371/journal.pone.0013743.g009
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neurogenesis.
Recent work has shown that reduced protein fucosylation, as a
result of gmds mutation in twohead (twd) mutants, results in defects in
the migration of vagus motor neuron progenitors [46]. However,
they argued that Notch signaling is unaltered, based on several
lines of evidence. First, they concluded from semi-quantitative RT-
PCR analyses, that expression of her4, a downstream effector in the
Notch pathway, was unchanged, but their data suggests that her4
expression may indeed be decreased. On the other hand, we show
using quantitative RT-PCR in our Fig. 7 that her4 is reduced in srn
mutants. Second, Ohata et al. analyzed motor neuron number and
patterning by in situ for islet1 and islet2 and concluded that motor
neuron number and patterning are unaltered in twd. On the other
hand, we show that the number of neurons assayed by islet1 and
islet2 in situ [16] and by islet1/2 immunostaining at 24 hpf (Fig. S5)
is increased in srn mutants. Thus, detailed analyses of neural and
glial phenotypes and analyses of additional Notch target genes in
twd mutants may help resolve this apparent discrepancy.
Previous work suggested that Fringe, a glycosyltransferase
that glycosylates specific sites on the Notch extracellular domain
during its intracellular processing, modulates Notch activity
[29,47,48,49]. In srn, both O- and N-fucosylation are compro-
mised due to reduced production of fucose moieties. Fringe acts
one step downstream of O-fucosylation, adding N-glycans onto
fucosylated sites. We speculate that Fringe loss of function may
result in similar, but milder, deficits than in srn mutants. Indeed,
recent work suggested that lunatic fringe (Lfng), a known modifier of
Notch, promotes the lateral inhibition of neurogenesis, that Lfng
loss of function by morpholino knockdown leads to increased
expression of proneural genes and increased neurogenesis, and
that transgenic overexpression of Lfng decreases neurogenesis [50].
These observations are consistent with our results, and further
support our conclusion that dysregulated glycosylation of Notch
and its ligands results in Notch signaling deficiency and leads to
increased neurogenesis.
While deficiencies in Notch-Delta signaling underlie some srn
phenotypes, other srn phenotypes are likely to be independent of
this pathway. Srn mutants exhibit prominent defects in retinotectal
connectivity that are quite different from those observed in
mutants in the Notch-Delta pathway such as des and dla in which
no defects in retinotectal axon branching are observed, and from
the dramatic reduction in retinal ganglion cell number and axon
pathfinding observed in mib. We present several lines of evidence
that support the conclusion that some, but clearly not all, of the
mechanisms underlying the neural phenotypes in srn are Notch-
dependent. Future work will focus on identifying the fucosylated
proteins that mediate the neural deficits that are independent of
Notch-Delta signaling.
It seems likely that the regulation of Notch signaling by
fucosylation is context dependent, i.e. different aspects of neural
development require specific types and extent of fucosylation and
other modifications of Notch receptors and/or ligands, in a
particular spatiotemporal fashion. Our results do not completely
rule out the possibility that Notch signaling may contribute, in a
specific spatiotemporal context, to the synaptic defects and retinal
ganglion cell arborization defects in srn, and this will only be
resolved once the relevant fucosylation targets are identified.
Srn as a zebrafish model for congenital disorders of
glycosylation
Over the last decade, a large number of human genetic diseases
with aberrant glycoprotein synthesis have been identified and
grouped as congenital disorders of glycosylation (CDG). Since
glycosylation is essential for the function of many proteins, it is not
surprising that disruption of glycosylation can lead to severe, multi-
systemic phenotypes, including neurodevelopmental and cognitive
disorders. In srn mutants, the gmds mutation largely abolishes the
synthesis of GDP-fucose, resulting in reduction or elimination of
both O-linked and N-linked fucosylation of Notch and many other
proteins. Thus it is possible that disruption of O- as well as N-
linked glycosylation of Notch and other proteins contributes to
CDG IIc pathogenesis, although this has not been examined
extensively in humans.
There are several reports of neural deficits in CDGIIc patients,
including severe mental retardation, microcephaly, cortical
atrophy, seizures, psychomotor retardation and hypotonia
[2,4,51]. These clinical observations are consistent with the CNS
and PNS cellular phenotypes observed in srn. Giving the
advantage of performing imaging, genetic and pharmacological
manipulations in zebrafish, srn will be a useful tool to guide future
analyses in human CDG IIc patients and contribute to a better
understanding of the mechanisms responsible for this devastating
disorder that affects nervous system and other organ development.
Supporting Information
Figure S1 Gmds mRNA localization by in situ hybridization in
wild type zebrafish embryos from 12 to 72 hpf. In situ
hybridization was performed as described previously (Panzer et
al., 2005), with anti-sense (A–E) gmds probe; sense probe was used
as a control (F). Several hundred embryos from several carrier
pairs were used from 6 to 72 hpf. A. From 6 to 12 hpf, gmds
transcripts are expressed throughout the embryo. B. By 24 hpf,
gmds transcripts are highly expressed in the CNS and are also
expressed in somites at lower levels. C, D. Gmds mRNA
expression is present in the CNS at 48 (C) and 72 (D) hpf, with
transcripts more abundant in brain than spinal cord.
Found at: doi:10.1371/journal.pone.0013743.s001 (2.49 MB EPS)
Figure S2 Modeling of zebrafish GMDS protein structure.
Because of the high degree of amino acid sequence conservation
between zebrafish and human GMDS, we reasoned that it would
be informative to superimpose the zebrafish GMDS sequence onto
the human GMDS crystal structure; this was done using a search
of the using a search of the Protein Data Bank database (www.pdb.
org) and MODELLER and PYMOL software. The wild type
(brown rods) and srn (blue rods) primary amino acid sequence was
modeled onto the human GMDS protein crystal structure. A: As
in the srn mutation, Valine was substituted for Glycine at residue
178 and an energy minimization calculation was performed.
When the srn mutation is present, the Valine deforms a nearby
Glutamate residue, Glu155. This change is predicted to push away
the substrate GDP-manose, resulting in loss of function. B: To
understand how the movement of Glu155 could affect surround-
ing amino acids, the wild type structure (brown sticks) was
examined in more detail. Three ordered H2O molecules exist
between the negatively charged group on Glu155 and the
negatively charged phosphate group on GDP. The bond lengths
between water oxygens and phosphate or carboxylic acid oxygens
are appropriate to form hydrogen bonds to coordinate GDP to
Glu155.
Found at: doi:10.1371/journal.pone.0013743.s002 (0.83 MB EPS)
Figure S3 GDP-fucose rescue of srn and morpholino knock-
down of gmds. A. RT-PCR showed .80% of gmds transcript was
mis-spliced after gmds morpholino (4 ng) injection. B–E. External
phenotypes in srn and gmds morphants (E) include tail bend
(compare B, wild type with C, srn) which is rescued after GDP-
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showed reduced AAL staining compared to wild type (F) which is
rescued after GDP-fucose supplementation (H). J–M. srn (K) and
gmds morphants (M) showed increased Mauthner neuron number
compared to wild type (J) a phenotype that is rescued after GDP-
fucose supplementation (L). N–Q. srn (O) and gmds morphants
(Q) showed reduced GFAP+ glia in the spinal cord compared to
wild type (N), a phenotype that is rescued after GDP-fucose
supplementation (P). R–U. srn (S) and gmds morphants (U)
showed increased neuromuscular synapses compared to wild type
(R), a phenotype that is rescued after GDP-fucose supplementation
(T). Scale bar =40 mm. In each experiment, at least 10 srn,
normal siblings, gmds morphants or GDP-fucose rescued srn
mutant embryos were assessed at 48 hpf. These results show that
GDP-fucose rescues external and neural defects in srn mutants
and that gmds knockdown by morpholino phenocopies srn
phenotypes. Together, these further support the conclusions that
gmds is the gene mutated in srn, that the fucose metabolism
pathway is deficient in srn mutants, and that the resulting lack
GDP-fucose is the cause of the srn mutant phenotypes, rather than
the accumulation of the substrate, GDP-mannose.
Found at: doi:10.1371/journal.pone.0013743.s003 (6.55 MB
EPS)
Figure S4 Zn5+ cell number is reduced in mib but not srn, des
or dla compared to wild type embryos. The number of Zn5+ cells
was counted from embryos at 48 and 72 hpf after immunostaining
with Zn5 antibody and confocal reconstruction of the motor
neuron pool. At 48 hpf, Zn5+ cell number per hemisegment was
similar among wild type (4662), srn (4961), des (5262) and dla
(4662) embryos, and is significantly reduced in mib mutant
embryos (2762) (1 hemisegment in each of 6–9 48 hpf embryos
counted of each genotype; one-way ANOVA, Bonferroni’s
Multiple Comparison Test, only mib is significantly different
compared to other mutants and wild type, p,0.001). At 72 hpf,
Zn5+ cell number per hemisegment was similar among wild type
(6362), srn (6261), des (6362) and dla (6162) embryos, and is
significantly reduced in mib mutant embryos (3662) (1 hemiseg-
ment in each of 6–10 72 hpf embryos counted of each genotype;
one-way ANOVA, Bonferroni’s Multiple Comparison Test; only
mib is significantly different compared to other mutants and wild
type, * p,0.001).
Found at: doi:10.1371/journal.pone.0013743.s004 (0.37 MB
EPS)
Figure S5 Immunostaining of Zn5, Islet1/2 and GFAP, and
quantification of Zn5+ cell patterning defects. A. At 24 hpf, Islet1/
2 staining is increased in srn mutants compared to WT embryos,
in primary motor neurons and Rohon-Beard neurons, identified
based on their morphology and location in the spinal cord. Dashed
lines indicate segment boundaries. B. At 48 hpf, in WT embryos,
Zn5+ cells are also Islet1/2+. In srn mutants, Islet1/2 expression is
reduced and majority of Zn5+ cells are not Islet1/2+. C. Zn5 and
GFAP immunostaining in WT and srn mutants at 48 hpf, showing
the spatial relationship between these markers. D. GFAP staining
in HuC:GFP embryos at 48 hpf, showing the spatial relationship
between neuron cell bodies and GFAP+ processes in the spinal
cord. Scale bar =40 mm. E–H. Quantification of Zn5+ cell
patterning defects. There are 3–5 Zn5+ cell at every 20 mm
interval in WT and des mutants, 1–9 in srn, dla mutants and
medium dose DAPT treated embryos, and 0–3 in mib and high
dose DAPT treated embryos, consistent with clumping and gaps in
the spinal cord. Data from a representative embryos is shown in E
and G. The distribution of all embryos is shown in F and H (4–9
embryos for each; Kolmogorov-Smirnov test, p,0.05).
Found at: doi:10.1371/journal.pone.0013743.s005 (5.80 MB
EPS)
Figure S6 Reduction in Notch-Delta signaling accounts for
some srn phenotypes in the retina. A. Retina patterning was
examined with immunostaining using antibody Zn5 at 72 hpf.
Retina cell patterning appears grossly normal in srn, des, dla and
medium dose DAPT treated embryos, but in mib and high does
DAPT treated embryos retinal ganglion cell number is reduced,
probably due to increased cell death, as previously reported
(Bernardos et al., 2005) (8 embryos, 2 carrier pairs were
examined). Scale bar =40 mm. B. Glial cells in the retina were
examined after immunostaining with anti-GFAP antibody. In the
retina, the number of radially oriented GFAP+ Muller cells is
decreased in srn and mib and medium dose DAPT treated
embryos, but not in des or dla (8 embryos, 2 carrier pairs were
examined). Scale bar =40 mm. These results suggest that a
reduction in Notch-Delta signaling may account for the glial
defects observed in srn mutants.
Found at: doi:10.1371/journal.pone.0013743.s006 (2.16 MB
EPS)
Figure S7 NICD overexpression suppresses the increased
Mauthner neuron phenotype in gmds morphants. A. AAL staining
is reduced in gmds morphants overexpressing NICD, but not in
WT embryos or WT embryos overexpressing NICD. B. WT
embryos have a pair of Mauthner neurons. WT overexpressing
NICD showed dramatic hindbrain patterning defects, resulting in
an almost complete loss of Mauthner neurons. gmds morphants
overexpressing NICD showed similar reduction of Mauthner
neurons. This result suggests NICD overexpression suppresses the
increase of Mauthner neurons observed in gmds morphants and
thus supports our conclusion that reduction of Notch-Delta
signaling in srn mutants is responsible for the neurogenesis defects
(3–4 embryos assessed for each manipulation). Scale bar =20 mm.
Found at: doi:10.1371/journal.pone.0013743.s007 (2.95 MB
EPS)
Figure S8 Muscle patterning is grossly normal in srn mutants.
Slow muscle fibers were examined with F59 antibody and glia cells
in the spinal cord were examined with GFAP antibody. While
there is an obvious reduction of GFAP+ glia cells in the spinal cord
in srn mutants, the patterning of slow muscle fibers is similar in srn
and wild type embryos at 48 hpf. Previous work showed that fast
muscle fiber number and patterning are unaltered in srn
compared to wild type embryos at 48 hpf (Panzer et al., 2005; 3
embryos, 1 carrier pair were examined). Scale bar =200 mm.
Found at: doi:10.1371/journal.pone.0013743.s008 (1.86 MB
EPS)
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